Dr. Reddy’s Laboratories (NYSE: RDY) has launched the authorized generic version of GlaxoSmithKline’s (NYSE: GSK) Imitrex (sumatriptan succinate) tablets 25mg ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE